Baseline plasma matrix metalloproteinase 9 (MMP9) to predict overall survival (OS) benefit from bevacizumab (BEV) in newly diagnosed glioblastoma (GBM): Retrospective analysis of AVAglio.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 2020-2020 ◽  
Author(s):  
Olivier L. Chinot ◽  
Josep Garcia ◽  
Sylvie Romain ◽  
Cedric Revil ◽  
Timothy Cloughesy ◽  
...  
Medicine ◽  
2016 ◽  
Vol 95 (17) ◽  
pp. e3288 ◽  
Author(s):  
Gaurav Lachuriya ◽  
Ravindra Kumar Garg ◽  
Amita Jain ◽  
Hardeep Singh Malhotra ◽  
Arvind Kumar Singh ◽  
...  

2007 ◽  
Vol 6 (1) ◽  
pp. 102-102
Author(s):  
E VELOT ◽  
I ERNENS ◽  
B HAAS ◽  
C JEANTY ◽  
D ROUY ◽  
...  

2005 ◽  
Vol 43 (05) ◽  
Author(s):  
F Thieringer ◽  
E Meyer ◽  
P Czochra ◽  
U Schmitt ◽  
JF Garcia-Lazaro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document